Avacta Group (LSE:AVCT) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Avacta Group Dividend Payout Ratio?

Avacta Group's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Avacta Group's Dividend Payout Ratio or its related term are showing as below:

LSE:AVCT's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-05), the Dividend Yield % of Avacta Group is 0.00%.

Avacta Group's Dividends per Share for the months ended in Dec. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Avacta Group Dividend Payout Ratio Historical Data

The historical data trend for Avacta Group's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Dividend Payout Ratio Chart

Avacta Group Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

Avacta Group Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Avacta Group's Dividend Payout Ratio

For the Biotechnology subindustry, Avacta Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avacta Group's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Avacta Group's Dividend Payout Ratio falls into.

Avacta Group Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Avacta Group's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-0.133
	=	N/A

Avacta Group's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.08
	=	N/A

Avacta Group (LSE:AVCT) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Avacta Group Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Avacta Group's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Avacta Group (LSE:AVCT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (LSE:AVCT) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

AVCTF:USA RTQ1:Germany

Address

Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA

Website

https://www.avacta.com

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group (LSE:AVCT) Headlines

No Headlines